Skip to main content

Table 2 HIV-1 nucleic acid detection in urine samples

From: Detection and molecular characterization of urinary tract HIV-1 populations

Group

Positive samples

# of subjects with positive samples

Supernatant

Pellet

Total

Supernatant

Pellet

Any

Overall

 Samples n = 97

 Subjects n = 20

13 (13.4%)

14 (14.4%)

27 (13.9%)

8 (40%)

7 (35%)

8 (40%)

Treatment naïve

 Samples n = 84

 Subjects n = 20

12 (14.3%)

13 (15.5%)

25 (15.2%)

8 (40%)

7 (35%)

8 (40%)

Virological failure (VL > 1000 RNA copies/ml)

 Samples n = 13

 Subjects n = 7a

0 (0%)

1 (7.7%)

1 (3.8%)

0 (0%)

1 (14.3%)

1 (14.3%)

Virally suppressed/low level viremia (VL < 1000 RNA copies/ml)

 Samples n = 21

 Subjects n = 13b

1 (4.8%)

0 (0%)

1 (2.4%)

1 (7.7%)

0 (0%)

1 (7.7%)

  1. aSubject IDs with VL > 1000 RNA copies/ml: 038, 051, 100, 121, 662, 664, 732
  2. bSubject IDs with VL < 1000 RNA copies/ml: 030, 051, 074, 100, 121, 614, 236, 747, 658, 664, 668, 705, 732